BRIEF-Pathway Healthcare Announces Research Collaboration With Tilray Canada

Reuters2021-02-18

Feb 17 (Reuters) - Pathway Healthcare Corp:

* PATHWAY HEALTHCARE CORP - ANNOUNCES A RESEARCH COLLABORATION WITH TILRAY CANADA

* PATHWAY HEALTHCARE CORP - MEDICAL CANNABIS IN OLDER PATIENTS STUDY IS A 6-MONTH OBSERVATIONAL STUDY SPONSORED BY TILRAY

* PATHWAY HEALTHCARE - MCOPS TO EXAMINE IMPACT OF MEDICAL CANNABIS ON CHRONIC PAIN, SLEEP, QUALITY OF LIFE, PRESCRIPTION MEDICATION USE IN PATIENTS OLDER THAN 50 YRS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Paithorn
2021-02-18
Paithorn
Hope this augurs well for the price

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2112859526?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-02-18 04:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2112859526","market":"us","top_or_hot":-1,"title":"BRIEF-Pathway Healthcare Announces Research Collaboration With Tilray Canada","media":"Reuters","content":"<html><body><p>Feb 17 (Reuters) - Pathway Healthcare Corp:</p><p>   * PATHWAY HEALTHCARE CORP - ANNOUNCES A RESEARCH COLLABORATION WITH TILRAY CANADA</p><p>   * PATHWAY HEALTHCARE CORP - MEDICAL CANNABIS IN OLDER PATIENTS STUDY IS A 6-MONTH OBSERVATIONAL STUDY SPONSORED BY TILRAY</p><p>   * PATHWAY HEALTHCARE - MCOPS TO EXAMINE IMPACT OF MEDICAL CANNABIS ON CHRONIC PAIN, SLEEP, QUALITY OF LIFE, PRESCRIPTION MEDICATION USE IN PATIENTS OLDER THAN 50 YRS</p><p>Source text for Eikon:   Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pathway Healthcare Announces Research Collaboration With Tilray Canada</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pathway Healthcare Announces Research Collaboration With Tilray Canada\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-18 04:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Feb 17 (Reuters) - Pathway Healthcare Corp:   * PATHWAY HEALTHCARE CORP - ANNOUNCES A RESEARCH COLLABORATION WITH TILRAY CANADA   * PATHWAY HEALTHCARE CORP - MEDICAL CANNABIS IN OLDER PATIENTS STUDY ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2112859526","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2112859526","pubTimestamp":1613595081,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Feb 17 (Reuters) - Pathway Healthcare Corp:   * PATHWAY HEALTHCARE CORP - ANNOUNCES A RESEARCH COLLA","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"Briek-Pathway Healthcare宣布与Tilray Canada合作研究","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":1},"content_text":"Feb 17 (Reuters) - Pathway Healthcare Corp:   * PATHWAY HEALTHCARE CORP - ANNOUNCES A RESEARCH COLLABORATION WITH TILRAY CANADA   * PATHWAY HEALTHCARE CORP - MEDICAL CANNABIS IN OLDER PATIENTS STUDY IS A 6-MONTH OBSERVATIONAL STUDY SPONSORED BY TILRAY   * PATHWAY HEALTHCARE - MCOPS TO EXAMINE IMPACT OF MEDICAL CANNABIS ON CHRONIC PAIN, SLEEP, QUALITY OF LIFE, PRESCRIPTION MEDICATION USE IN PATIENTS OLDER THAN 50 YRSSource text for Eikon:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":384948168,"gmtCreate":1613609956554,"gmtModify":1704882655113,"author":{"id":"3574339658121584","authorId":"3574339658121584","name":"Paithorn","avatar":"https://static.tigerbbs.com/30f076bb56b9bb0a0a5dddcb1250f214","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3574339658121584","authorIdStr":"3574339658121584"},"htmlText":"Hope this augurs well for the price&nbsp;","listText":"Hope this augurs well for the price&nbsp;","text":"Hope this augurs well for the price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384948168","repostId":2112859526,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2112859526"}